The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients

Keith G. LeBlanc, Matthew P. Hughes, Daniel J Sheehan

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Skin cancers are common in organ transplant recipients (OTRs). In this review, we discuss the epidemiology of and risk factors for cutaneous neoplasms, particularly squamous cell carcinoma (SCC) in OTRs. The pathogenesis of SCC is reviewed, as well as the potential mechanisms for tumor progression and metastasis associated with two commonly used immunosuppressive medications: tacrolimus and cyclosporine. Finally, we discuss the mechanism of action and potential preventative use of sirolimus, a member of a newer class of immunosuppressants, the mammalian target of rapamycin inhibitors.

Original languageEnglish (US)
Pages (from-to)744-749
Number of pages6
JournalDermatologic Surgery
Volume37
Issue number6
DOIs
StatePublished - Jan 1 2011

Fingerprint

Skin Neoplasms
Sirolimus
Immunosuppressive Agents
Squamous Cell Carcinoma
Transplants
Skin
Tacrolimus
Cyclosporine
Action Potentials
Epidemiology
Neoplasm Metastasis
Neoplasms
Transplant Recipients

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients. / LeBlanc, Keith G.; Hughes, Matthew P.; Sheehan, Daniel J.

In: Dermatologic Surgery, Vol. 37, No. 6, 01.01.2011, p. 744-749.

Research output: Contribution to journalReview article

@article{4ab9bf62c2164457b44659d4c0752343,
title = "The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients",
abstract = "Skin cancers are common in organ transplant recipients (OTRs). In this review, we discuss the epidemiology of and risk factors for cutaneous neoplasms, particularly squamous cell carcinoma (SCC) in OTRs. The pathogenesis of SCC is reviewed, as well as the potential mechanisms for tumor progression and metastasis associated with two commonly used immunosuppressive medications: tacrolimus and cyclosporine. Finally, we discuss the mechanism of action and potential preventative use of sirolimus, a member of a newer class of immunosuppressants, the mammalian target of rapamycin inhibitors.",
author = "LeBlanc, {Keith G.} and Hughes, {Matthew P.} and Sheehan, {Daniel J}",
year = "2011",
month = "1",
day = "1",
doi = "10.1111/j.1524-4725.2011.01973.x",
language = "English (US)",
volume = "37",
pages = "744--749",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients

AU - LeBlanc, Keith G.

AU - Hughes, Matthew P.

AU - Sheehan, Daniel J

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Skin cancers are common in organ transplant recipients (OTRs). In this review, we discuss the epidemiology of and risk factors for cutaneous neoplasms, particularly squamous cell carcinoma (SCC) in OTRs. The pathogenesis of SCC is reviewed, as well as the potential mechanisms for tumor progression and metastasis associated with two commonly used immunosuppressive medications: tacrolimus and cyclosporine. Finally, we discuss the mechanism of action and potential preventative use of sirolimus, a member of a newer class of immunosuppressants, the mammalian target of rapamycin inhibitors.

AB - Skin cancers are common in organ transplant recipients (OTRs). In this review, we discuss the epidemiology of and risk factors for cutaneous neoplasms, particularly squamous cell carcinoma (SCC) in OTRs. The pathogenesis of SCC is reviewed, as well as the potential mechanisms for tumor progression and metastasis associated with two commonly used immunosuppressive medications: tacrolimus and cyclosporine. Finally, we discuss the mechanism of action and potential preventative use of sirolimus, a member of a newer class of immunosuppressants, the mammalian target of rapamycin inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=79959855318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959855318&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2011.01973.x

DO - 10.1111/j.1524-4725.2011.01973.x

M3 - Review article

C2 - 21605234

AN - SCOPUS:79959855318

VL - 37

SP - 744

EP - 749

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 6

ER -